Elfie, a free digital health super-app that rewards people for taking care of their health, announced the closing of its $12 million Series A funding round. The funding round was led by White Star Capital, with participation from LifeX Ventures, and followed by support from Integra Partners, FEBE Ventures, and Hustle Fund.
Problem being addressed: Elfie is on a mission to make healthy living easier and more rewarding for the millions of people living with chronic conditions and for those who just want to monitor their health. By combining self-monitoring tools, AI-driven coaching, and real-world rewards, Elfie empowers users to stay on track with their treatment plans and build better health habits.
Momentum: Since launching in 2021, Elfie has grown to 700,000+ users across four continents, helping individuals self-manage chronic illnesses like obesity, IBS, IBD, high blood pressure, high cholesterol, and diabetes. The app’s unique approach, which combines clinically validated interventions with gamification mechanics and behavioral science, has driven a 30%+ improvement in adherence for key pharmaceutical partners and measurable health improvements among users.
The users are rewarded for completing critical but straightforward actions such as monitoring health metrics like blood pressure or glucose levels, logging medication, and engaging with educational content. This continuous positive reinforcement encourages sustained participation and leads to better health outcomes over time.
Elfie’s traction has already led to multimillion-dollar partnerships with global pharma leaders. And these partnerships aim to improve treatment adherence for patients with chronic conditions, while generating real-world data to support market access and ongoing research. Plus, Elfie is also piloting programs with global insurance carriers, aiming to reduce medical claim costs and loss ratios through better health awareness and medication adherence.
Elfie’s app is now available across 35 countries, with plans to scale to 10 additional countries by the end of 2025. And the app is medically approved across multiple regions and remains 100% free for users, with all revenue generated through enterprise partnerships.
How the funding will be used: With this funding, Elfie plans to accelerate user acquisition through new pharma and insurance partnerships, expand the team in the United States, adding talent in product, engineering, and go-to-market, and launch Elfie Research, a decentralized clinical trial platform to generate real-world evidence and support clinical innovation.
KEY QUOTES:
“It’s a privilege to lead a company with such meaningful social impact. Thanks to our strategic partnerships with the pharmaceutical industry, we’re able to offer the world’s most complete and engaging health app, for free. We believe the only scalable way to fight the global pandemic of non-communicable conditions is to make self-monitoring fun, rewarding, and accessible to all. That’s our mission: to encourage everyone, everywhere, to take charge of their health. This funding round marks a significant milestone as we scale our impact through deeper collaborations with insurers and employers.”
Ofir Ejnes, CEO & co-founder of Elfie
“Elfie is tapping into three enormous markets, pharma, insurance, and clinical research, at exactly the right time. They’ve built a scalable, data-driven platform that improves outcomes for patients while creating measurable ROI for partners. We’re thrilled to support their next phase of growth.”
Eric Martineau-Fortin, Managing Partner at White Star Capital
